Список литературы

1. Арутюнян В.М., Акопян Г.С. Периодическая болезнь (этиопатогенетические и клинические аспекты). Москва: МИА 2000.

2. Амарян Г.Г., Саркисян Т.Ф., Айрапетян А.С. Семейная средиземноморская лихорадка у детей (периодическая болезнь): клинические и генетические аспекты. Методическое пособие. Ереван: 2012.

3. Fedorov ES, Salugina SO, Kuzmina NN. Familial Mediterranean fever (a periodic disease): The present-day view of the problem. Mod Rheumatol J. 15 март 2013 г.; 0(1): 24. doi: 10.14412/1996-7012-2013-2363

4. Ben-Chetrit E, Touitou I. Familial Mediterranean Fever in the World. Arthritis Rheum. 15 октябрь 2009 г.; 61(10): 1447 - 53. doi: 10.1002/art.24458

5. Gattorno M, редактор. Familial Mediterranean Fever [Интернет]. Т. 3. Cham: Springer International Publishing; 2015 [цитируется по 2 октябрь 2022 г.]. (Rare Diseases of the Immune System). Доступно на: http://link.springer.com/10.1007/978-3-319-14615-7 doi: 10.1007/978-3-319-14615-7

6. Ben-Zvi I, Herskovizh C, Kukuy O, Kassel Y, Grossman C, Livneh A. Familial Mediterranean fever without MEFV mutations: a case-control study. Orphanet J Rare Dis. декабрь 2015 г.; 10(1): 34. doi: 10.1186/s13023-015-0252-7

7. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-Wolf H, Livneh A, и др. Clinical disease among patients heterozygous for familial mediterranean fever. Arthritis Rheum. июнь 2009 г.; 60(6): 1862 - 6. doi: 10.1002/art.24570

8. Hentgen V, Grateau G, Kone-Paut I, Livneh A, Padeh S, Rozenbaum M, и др. Evidence-based recommendations for the practical management of Familial Mediterranean Fever. Semin Arthritis Rheum. декабрь 2013 г.; 43(3): 387 - 91. doi: 10.1016/j.semarthrit.2013.04.011

9. The International FMF Consortium. Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever. Cell. август 1997 г.; 90(4): 797 - 807. doi: 10.1016/S0092-8674(00)80539-5

10. Fedorov ES, Salugina SO. Familial Mediterranean fever (periodic disease): history or a real problem. Mod Rheumatol J. 16 сентябрь 2018 г.; 12(3): 61 - 9. doi: 10.14412/1996-7012-2018-3-61-69

11. Hashkes PJ, Laxer RM, Simon A, редакторы. Textbook of Autoinflammation [Интернет]. Cham: Springer International Publishing; 2019 [цитируется по 2 октябрь 2022 г.]. Доступно на: http://link.springer.com/10.1007/978-3-319-98605-0 doi: 10.1007/978-3-319-98605-0

12. Touitou I, Sarkisian T, Medlej-Hashim M, Tunca M, Livneh A, Cattan D, и др. Country as the primary risk factor for renal amyloidosis in familial mediterranean fever. Arthritis Rheum. май 2007 г.; 56(5): 1706 - 12. doi: 10.1002/art.22507

13. Federici S, Vanoni F, Ben-Chetrit E, Cantarini L, Frenkel J, Goldbach-Mansky R, и др. An International Delphi Survey for the Definition of New Classification Criteria for Familial Mediterranean Fever, Mevalonate Kinase Deficiency, TNF Receptor-associated Periodic Fever Syndromes, and Cryopyrin-associated Periodic Syndrome. J Rheumatol. апрель 2019 г.; 46(4): 429 - 36. doi: 10.3899/jrheum.180056

14. Sohar E, Gafni J, Pras M, Heller H. Familial Mediterranean fever. Am J Med. август 1967 г.; 43(2): 227 - 53. doi: 10.1016/0002-9343(67)90167-2

15. Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheum 1997; 40: 1879 - 85. doi: 10.1002/1529-0131(199710)40: 10< 1879: AID-ART23> 3.0.CO; 2-M.

16. Рисунок 46 F, Рисунок 47 S, Рисунок 48 ZB, Aktay N, Рисунок 49 N, Рисунок 50 A, и др. A new set of criteria for the diagnosis of familial Mediterranean fever in childhood. Rheumatology. апрель 2009 г.; 48(4): 395 - 8. doi: 10.1093/rheumatology/ken509

17. Gattorno M, Hofer M, Federici S, Vanoni F, Bovis F, Aksentijevich I, и др. Classification criteria for autoinflammatory recurrent fevers. Ann Rheum Dis. август 2019 г.; 78(8): 1025 - 32. doi: 10.1136/annrheumdis-2019-215048

18. Federici S, Sormani MP, Ozen S, Lachmann HJ, Amaryan G, Woo P, и др. Evidence-based provisional clinical classification criteria for autoinflammatory periodic fevers. Ann Rheum Dis. май 2015 г.; 74(5): 799 - 805. doi: 10.1136/annrheumdis-2014-206580

19. Рисунок 51 ZB, Рисунок 52 N, Uncu N, Рисунок 53 BA, Рисунок 54 F. Familial Mediterranean fever-associated diseases in children. QJM. 30 декабрь 2016 г.; hcw230. doi: 10.1093/qjmed/hcw230

20. Demir S, Sag E, Dedeoglu F, Ozen S. Vasculitis in Systemic Autoinflammatory Diseases. Front Pediatr. 3 декабрь 2018 г.; 6: 377. doi: 10.3389/fped.2018.00377

21. Yildiz M, Adrovic A, Tasdemir E, Baba-zada K, Aydin M, Koker O, и др. Evaluation of co-existing diseases in children with familial Mediterranean fever. Rheumatol Int. январь 2020 г.; 40(1): 57 - 64. doi: 10.1007/s00296-019-04391-9

22. Рисунок 55 B, Рисунок 56 Рисунок 57, Рисунок 58 ZS, Рисунок 59 E, Akkaya-Ulum ZY, Рисунок 60, и др. Comorbidities in familial Mediterranean fever: analysis of 2000 genetically confirmed patients. Rheumatology. 1 июнь 2020 г.; 59(6): 1372 - 80. doi: 10.1093/rheumatology/kez410

23. Рисунок 61 HE, Batu ED, Demir S, et al. Comparison of patients with familial Mediterranean fever accompanied with sacroiliitis and patients with juvenile spondyloarthropathy. Clin Exp Rheumatol 2017; 35 Suppl 108: 124 - 7.

24. Ozer E, Seker D, Taner E, et al. The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever. Clin Exp Rheumatol 2018; 36: 141 - 5.

25. Рамеев В.В., Симонян А.Х., Саркисова И.А., et al. Амилоидоз и наследственные периодические аутовоспалительные заболевания. Клиницист 2008; 3. https://www.elibrary.ru/item.asp?id=14310188 (accessed 28 May 2021).

26. Vinceneux P, Pouchot J. De la maladie Рисунок 62 l'amylose. Presse Рисунок 63. июль 2005 г.; 34(13): 958 - 66. doi: 10.1016/S0755-4982(05)84087-4

27. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney inter 2013; 3: 1 - 150.

28. Lidar M, Yaqubov M, Zaks N, et al. The prodrome: a prominent yet overlooked pre-attack manifestation of familial Mediterranean fever. J Rheumatol 2006; 33: 1089 - 92.

29. Yenokyan G, Armenian HK. Triggers for Attacks in Familial Mediterranean Fever: Application of the Case-Crossover Design. Am J Epidemiol. 15 май 2012 г.; 175(10): 1054 - 61. doi: 10.1093/aje/kwr460

30. Petty RE, Laxer RM, Lindsley CB, et al. Textbook of pediatric rheumatology. 8th ed. Philadelphia: Elsevier, Inc 2020.

31. Кузьмина Н.Н., Салугина С.О., Федоров Е.С. Аутовоспалительные заболевания и синдромы у детей. Москва: ИМА-ПРЕСС 2012.

32. Sari I, Birlik M, Kasifoglu T Familial Mediterranean fever: An update review. 2014; 1: 21 - 33.

33. Alghamdi M. Familial Mediterranean fever, review of the literature. Clin Rheumatol. август 2017 г.; 36(8): 1707 - 13. doi: 10.1007/s10067-017-3715-5

34. Ozdogan H, Ugurlu S. Familial Mediterranean Fever. Presse Medicale. февраль 2019 г.; 48(1): e61 - 76. doi: 10.1016/j.lpm.2018.08.014

35. Alsarah A, Alsara O, Laird-Fick HS. Cardiac manifestations of Familial Mediterranean fever. Avicenna J Med. октябрь 2017 г.; 07(04): 158 - 63. doi: 10.4103/ajm.AJM_78_17

36. Salah S, Hegazy R, Ammar R, Sheba H, AbdelRahman L. MEFV gene mutations and cardiac phenotype in children with familial Mediterranean fever: a cohort study. Pediatr Rheumatol. декабрь 2014 г.; 12(1): 5. doi: 10.1186/1546-0096-12-5

37. Gurkan OE, Dalgic B. Gastrointestinal Mucosal Involvement Without Amyloidosis in Children With Familial Mediterranean Fever. J Pediatr Gastroenterol Nutr. сентябрь 2013 г.; 57(3): 319 - 23. doi: 10.1097/MPG.0b013e318295fc65

38. Tutar E, Kutluk G, Bayrak NA, Ataizi Celikel C, Pehlivanoglu E, Ertem D. What is the diagnostic utility of endoscopic scoring systems in children? Turk J Gastroenterol. 1 февраль 2009 г.; 24(1): 22 - 9. doi: 10.4318/tjg.2013.0700

39. Рисунок 64, Рисунок 65, Рисунок 66, Kutlu T, Arsoy N, Erkan T. Association of Inflammatory Bowel Disease With Familial Mediterranean Fever in Turkish Children. J Pediatr Gastroenterol Nutr. май 2013 г.; 56(5): 498 - 502. doi: 10.1097/MPG.0b013e31827dd763

40. Рисунок 67 E, Demir F, Рисунок 68, Kalyoncu M, Рисунок 69 M. Endoscopic Findings of Children with Familial Mediterranean Fever. Pediatr Gastroenterol Hepatol Nutr. 2018 г.; 21(4): 271. doi: 10.5223/pghn.2018.21.4.271

41. Petrushkin H, Stanford M, Fortune F, Jawad AS. Clinical Review: Familial Mediterranean Fever - An Overview of Pathogenesis, Symptoms, Ocular Manifestations, and Treatment. Ocul Immunol Inflamm. 3 июль 2016 г.; 24(4): 422 - 30. doi: 10.3109/09273948.2015.1010012

42. Баранов А.А., Алексеева Е.И., editors. Ревматические болезни у детей. Москва: ПедиатрЪ 2016.

43. Adrovic A, Sahin S, Barut K, Kasapcopur O. Familial Mediterranean fever and periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome: shared features and main differences. Rheumatol Int. январь 2019 г.; 39(1): 29 - 36. doi: 10.1007/s00296-018-4105-2

44. Korkmaz C. Acute phase response in familial Mediterranean fever. Ann Rheum Dis. 1 январь 2002 г.; 61(1): 79 - 81. doi: 10.1136/ard.61.1.79

45. Тепаев Р.Ф. Синдром диссеминированного внутрисосудистого свертывания у детей. Диагностика и лечение. Педиатрическая Фармакология 2010; 7: 27 - 31.

46. De Vere-Tyndall A, Macauley D, Ansell BM. Disseminated intravascular coagulation complicating systemic juvenile chronic arthritis ("Still's disease"). Clin Rheumatol. декабрь 1983 г.; 2(4): 415. doi: 10.1007/BF02041564

47. Рисунок 70 H, Рисунок 71 I, Duman M, Рисунок 72 S, Irken G. Disseminated intravascular coagulation in pediatric patients: Clinical and Laboratory Features and Prognostic Factors Influencing the Survival. Pediatr Hematol Oncol. январь 2005 г.; 22(8): 679 - 88. doi: 10.1080/08880010500278749

48. Rajagopal R, Thachil J, Monagle P. Disseminated intravascular coagulation in paediatrics. Arch Dis Child. февраль 2017 г.; 102(2): 187 - 93. doi: 10.1136/archdischild-2016-311053

49. Tayer-Shifman O. E., Ben-Chetrit E. Familial Mediterranean fever and hypercoagulability//Mediterranean journal of hematology and infectious diseases. - 2011. - Т. 3. - N. 1.

50. Salah S. et al. Comparing D-dimer status in children with familial Mediterranean fever during and in between acute attacks//The Egyptian Rheumatologist. - 2018. - Т. 40. - N. 2. - С. 107 - 110.

51. Rajagopal R, Thachil J, Monagle P. Disseminated intravascular coagulation in paediatrics. Arch Dis Child. февраль 2017 г.; 102(2): 187 - 93. doi: 10.1136/archdischild-2016-311053

52. Yuan WH, Liu HC, Zeng LK, Liu XY, Zhao LX, Mo LX. [Change of Thrombelastography in Children's DIC and Analysis of Its Sensitivity and Specificity for Diagnosis of DIC]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2017 Jun; 25(3): 847 - 852. Chinese. doi: 10.7534/j.issn.1009-2137.2017.03.039. PMID: 28641648.

53. Геморрагические и тромботические заболевания и синдромы у детей и подростков: патогенез, клиника, диагностика, терапия и профилактика: монография/Б.И. Кузник, В.Г. Стуров, Н.Ю. Левшин [и др.]. - 2-е изд., перераб. и доп. - Новосибирск: Наука, 2018. - 524 с.

54. Ameri A, Anderson CM, Smith JH, Patel J. Thromboembolic Complications in a Pediatric Patient Population: Treatment with Direct Oral Anticoagulants. Monitoring of Treatment Efficiency with D-Dimer Levels and Safety Profile By Thromboelastogram. Blood. 5 ноябрь 2021 г.; 138 (Supplement 1): 4270 - 4270. doi: 10.1182/blood-2021-146948

55. Рисунок 73 M P, Salgado U A, Barriga G J, et al. Usefulness of the thromboelastogram in children: correlation with habitual coagulation tests. Rev Chil Pediatr. 2019; 90: 617 - 23. doi: 10.32641/rchped.v90i6.930.

56. Verma A, Hemlata. Thromboelastography as a novel viscoelastic method for hemostasis monitoring: Its methodology, applications, and constraints. Glob J Transfus Med. 2017 г.; 2(1): 8. doi: 10.4103/GJTM.GJTM_4_17

57. Ozen S, Demirkaya E, Erer B, Livneh A, Ben-Chetrit E, Giancane G, и др. EULAR recommendations for the management of familial Mediterranean fever. Ann Rheum Dis. апрель 2016 г.; 75(4): 644 - 51. doi: 10.1136/annrheumdis-2015-208690

58. Fraisse T. et al. Non-amyloid liver involvement in familial Mediterranean fever: A systematic literature review//Liver International. - 2020. - Т. 40. - N. 6. - С. 1269 - 1277.

59. Celkan T. et al. The anemia of familial Mediterranean fever disease//Pediatric hematology and oncology. - 2005. - Т. 22. - N. 8. - С. 657 - 665.

60. Mohamed R. et al. Carotid intima-media thickness, lipid profile, serum amyloid A and vitamin D status in children with familial Mediterranean fever//The Egyptian Rheumatologist. - 2020. - Т. 42. - N. 3. - С. 237 - 240.

61. Unal F. et al. Liver involvement in children with Familial Mediterranean fever//Digestive and Liver Disease. - 2012. - Т. 44. - N. 8. - С. 689 - 693.

62. Topouzian N. B., Bowie L. J. Familial Mediterranean fever in a fraternal twin: a laboratory evaluation//Annals of Clinical & Laboratory Science. - 1991. - Т. 21. - N. 3. - С. 205 - 215.

63. Uyanik A, Albayrak F, Uyanik MH, Dursun H, Keles M, Cetinkaya R. Antibodies directed to cyclic citrullinated peptides in familial Mediterranean fever. Rheumatol Int. февраль 2010 г.; 30(4): 467 - 71. doi: 10.1007/s00296-009-0993-5

64. Kholoussi S, Kholoussi N, Zaki ME, El-Bassyouni HT, Elnady H, Morcos B, и др. Immunological Evaluation in Patients with Familial Mediterranean fever. Open Access Maced J Med Sci. 9 февраль 2018 г.; 6(2): 310 - 3. doi: 10.3889/oamjms.2018.079

65. Karatay S, Yildirim K, Erdal A, Uzkeser H, Erdem FH, Yanmaz V. Anti-cyclic citrullinated peptide antibodies are not associated with familial Mediterranean fever. J Back Musculoskelet Rehabil. 5 март 2010 г.; 23(1): 21 - 3. doi: 10.3233/BMR-2010 - 0243

66. Majeed HA. Familial Mediterranean fever in children: the expanded clinical profile. QJM. 1 июнь 1999 г.; 92(6): 309 - 18. doi: 10.1093/qjmed/92.6.309

67. Breda, L., Nozzi, M., De Sanctis, S., & Chiarelli, F. (2010). Laboratory Tests in the Diagnosis and Follow-Up of Pediatric Rheumatic Diseases: An Update. Seminars in Arthritis and Rheumatism, 40(1), 53 - 72. doi: 10.1016/j.semarthrit.2008.12.

68. Голуб И.Е., Сорокина Л.В. Избранные вопросы по общей анестезиологии (методические рекомендации для клинических ординаторов, с правом переиздания). - 2005.

69. Михельсон В.А., В.А. Сидоров, and С.М. Степаненко. "Анестезия и интенсивная терапия в педиатрии." М.: "Дель рус (2007).

70. Salem GI, Gamal NM, Talaat EA, El-Hammady DH, Hammam N, Gheita TA. Clinical Impact of the ABO Blood Type in Patients with Rheumatic Diseases: Is there a Link to the ABO and Rhesus? Mediterr J Rheumatol. 2021 г.; 32(3): 237. doi: 10.31138/mjr.32.3.237

71. Рисунок 74 T, Рисунок 75 C, Cansu Рисунок 76, Korkmaz C. The frequency of sacroiliitis in familial Mediterranean fever and the role of HLA-B27 and MEFV mutations in the development of sacroiliitis. Clin Rheumatol. январь 2009 г.; 28(1): 41 - 6. doi: 10.1007/s10067-008-0980-3

72. Периодические лихорадки в практике детского врача/Р.Р. Шиляев, Е.Б. Копилова, Е.В. Харитонова, И.В. Менагаришвили//Вестник Ивановской медицинской академии. - 2013. - Т. 18. - N 4. - С. 51 - 55.

73. Рисунок 77 et al. Familial Mediterranean fever in children: report of a large series and discussion of the risk and prognostic factors of amyloidosis//European journal of pediatrics. - 1997. - Т. 156. - N. 8. - С. 619 - 623.

74. Said R. et al. Spectrum of renal involvement in familial Mediterranean fever//Kidney international. - 1992. - Т. 41. - N. 2. - С. 414 - 419.

75. Рисунок 78 S. et al. Simple markers for subclinical inflammation in patients with Familial Mediterranean Fever//Medical Science Monitor: International medical journal of experimental and clinical research. - 2015. - Т. 21. - С. 298.

76. Bourguiba R, Savey L, Aouba A, Deshayes S, Fain O, Martin-Silva N, и др. Le syndrome de Рисунок 79 aux mutations du Рисунок 80 du Рисунок 81 au TNF de type 1: un diagnostic Рисунок 82 de la Рисунок 83 familiale Рисунок 84 ne pas Рисунок 85 chez les patients d'origine Рисунок 86. Rev Рисунок 87 Interne. июль 2021 г.; 42(7): 459 - 64. doi: 10.1016/j.revmed.2020.08.007

77. Sag E, Bilginer Y, Ozen S. Autoinflammatory Diseases with Periodic Fevers. Curr Rheumatol Rep. июль 2017 г.; 19(7): 41. doi: 10.1007/s11926-017-0670-8

78. Soon GS, Laxer RM. Approach to recurrent fever in childhood. Can Fam Physician Med Fam Can 2017; 63: 756 - 62.

79. Рисунок 88 S, Ekim M, Рисунок 89 ZB, Рисунок 90 F, Acar B, Рисунок 91 D, и др. The value of procalcitonin measurements in children with familial Mediterranean fever. Rheumatol Int. ноябрь 2012 г.; 32(11): 3443 - 7. doi: 10.1007/s00296-011-2206-2

80. Lin S. G. et al. Role of procalcitonin in the diagnosis of severe infection in pediatric patients with fever and neutropenia - a systemic review and meta-analysis//The Pediatric Infectious Disease Journal. - 2012. - Т. 31. - N. 10. - С. e182 - e188.

81. Wacker C. et al. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis//The Lancet infectious diseases. - 2013. - Т. 13. - N. 5. - С. 426 - 435.

82. Щербина А.Ю. Первичные иммунодефициты - реалии XXI века. Вопросы Гематологиионкологии И Иммунопатологии В Педиатрии. 2016; 15: 8-9-9. doi: 10.24287/1726-1708-2016-15-1-8-9.

83. Аксенова В.А., Барышников Л.А., Клевно Н.И., et al. Новые возможности скрининга и диагностики различных проявлений туберкулезной инфекции у детей и подростков в России. Вопросы Современной Педиатрии 2011; 10: 16 - 22.

84. Aksenova VA, Klevno NI, Kazakov AV, Kudlay DA, Sevostyanova TA, Dementyeva EK. Preventive Tuberculosis Services Reduces the Risk of Local Forms of Tuberculosis Development in Children on Immunosuppressive Therapy: Retrospective Cohort Study. Curr Pediatr. 24 декабрь 2020 г.; 19(5): 346 - 51. doi: 10.15690/vsp.v19i5.2210

85. Рисунок 92 AL, DiNardo A, Saavedra B, Silva DR, Palmero D, Gegia M, и др. Point of care diagnostics for tuberculosis. Pulmonology. март 2018 г.; 24(2): 73 - 85. doi: 10.1016/j.rppnen.2017.12.002

86. Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. апрель 2014 г.; 13(4 - 5): 546 - 9. doi: 10.1016/j.autrev.2014.01.005

87. Plesca DA, Luminos M, Spatariu L, et al. Postinfectious arthritis in pediatric practice. Maedica. 2013; 8: 164 - 9.

88. Mazumder RN, Salam MA, Ali M, et al. Reactive arthritis associated with Shigella dysenteriae type 1 infection. J Diarrhoeal Dis Res. 1997; 15: 21 - 4.

89. Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis attributable to Shigella infection: a clinical and epidemiological nationwide study. Ann Rheum Dis. апрель 2005 г.; 64(4): 594 - 8. doi: 10.1136/ard.2004.027524

90. Steffen, Hirsch. Diagnostik der Lyme-Borreliose. Ther Umsch. 1 ноябрь 2005 г.; 62(11): 737 - 44. doi: 10.1024/0040-5930.62.11.737

91. Sood SK. Lyme Disease in Children. Infect Dis Clin North Am. июнь 2015 г.; 29(2): 281 - 94. doi: 10.1016/j.idc.2015.02.011

92. Long SS. Distinguishing Among Prolonged, Recurrent, and Periodic Fever Syndromes: Approach of a Pediatric Infectious Diseases Subspecialist. Pediatr Clin North Am. июнь 2005 г.; 52(3): 811 - 35. doi: 10.1016/j.pcl.2005.02.007

93. Ahmadinejad Z, Mansori S, Ziaee V, et al. Periodic Fever: a review on clinical, management and guideline for Iranian patients - part I. Iran J Pediatr 2014; 24: 1 - 13.

94. Nowalk A, Green M. Epstein-Barr Virus. Hayden RT, Wolk DM, Carroll KC, Tang YW, редакторы. Microbiol Spectr. 6 май 2016 г.; 4(3): 4.3.47. doi: 10.1128/microbiolspec.DMIH2-0011-2015

95. Houen G, Trier NH. Epstein-Barr Virus and Systemic Autoimmune Diseases. Front Immunol. 7 январь 2021 г.; 11: 587380. doi: 10.3389/fimmu.2020.587380

96. Shi T, Huang L, Tian J. Prevalence of Epstein-Barr Viral DNA among children at a single hospital in Suzhou, China. J Pediatr (Rio J). март 2022 г.; 98(2): 142 - 6. doi: 10.1016/j.jped.2021.05.006

97. Engelmann I, Petzold DR, Kosinska A, Hepkema BG, Schulz TF, Heim A. Rapid quantitative PCR assays for the simultaneous detection of herpes simplex virus, varicella zoster virus, cytomegalovirus, Epstein-Barr virus, and human herpesvirus 6 DNA in blood and other clinical specimens. J Med Virol. март 2008 г.; 80(3): 467 - 77. doi: 10.1002/jmv.21095

98. Adler SP, Marshall B. Cytomegalovirus Infections.; 11.

99. A. Ross S, Novak Z, Pati S, B. Boppana S. Overview of the Diagnosis of Cytomegalovirus Infection. Infect Disord - Drug Targets. 1 октябрь 2011 г.; 11(5): 466 - 74. doi: 10.2174/187152611797636703

100. Eisenstein EM, Wolf DG. Cytomegalovirus infection in pediatric rheumatic diseases: a review. Pediatr Rheumatol. декабрь 2010 г.; 8(1): 17. doi: 10.1186/1546-0096-8-17

101. Strick LB, Wald A. Diagnostics for Herpes Simplex Virus: Is PCR the New Gold Standard? Mol Diagn Ther. январь 2006 г.; 10(1): 17 - 28. doi: 10.1007/BF03256439

102. Looker KJ, Magaret AS, May MT, Turner KME, Vickerman P, Gottlieb SL, и др. Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012. DeLuca NA, редактор. PLOS ONE. 28 октябрь 2015 г.; 10(10): e0140765. doi: 10.1371/journal.pone.0140765

103. Levin MJ, Weinberg A, Schmid DS. Herpes Simplex Virus and Varicella-Zoster Virus. Hayden RT, Wolk DM, Carroll KC, Tang YW, редакторы. Microbiol Spectr. 6 май 2016 г.; 4(3): 4.3.49. doi: 10.1128/microbiolspec.DMIH2-0017-2015

104. Whitley RJ. Herpes simplex virus in children. Curr Treat Options Neurol. май 2002 г.; 4(3): 231 - 7. doi: 10.1007/s11940-002-0040-2

105. Xu F, Lee FK, Morrow RA, Sternberg MR, Luther KE, Dubin G, и др. Seroprevalence of Herpes Simplex Virus Type 1 in Children in the United States. J Pediatr. октябрь 2007 г.; 151(4): 374 - 7. doi: 10.1016/j.jpeds.2007.04.065

106. Slots J, Slots H. Bacterial and viral pathogens in saliva: disease relationship and infectious risk. Periodontol 2000. февраль 2011 г.; 55(1): 48 - 69. doi: 10.1111/j.1600-0757.2010.00361.x

107. Vince A, Dusek D. Imunosupresija i virusne infekcije u reumatskim bolestima [Immunosupression and viral infections in rheumatic diseases]. Reumatizam. 2007; 54(2): 58 - 62. Croatian. PMID: 18351141.

108. Eisenstein EM, Wolf DG. Cytomegalovirus infection in pediatric rheumatic diseases: a review. Pediatr Rheumatol. декабрь 2010 г.; 8(1): 17. doi: 10.1186/1546-0096-8-17

109. McQuillan G, Kruszon-Moran D, Flagg EW, et al. Prevalence of Herpes Simplex Virus Type 1 and Type 2 in Persons Aged 14 - 49: United States, 2015 - 2016. NCHS Data Brief. 2018; 1 - 8.

110. Indolfi G, Easterbrook P, Dusheiko G, Siberry G, Chang MH, Thorne C, и др. Hepatitis B virus infection in children and adolescents. Lancet Gastroenterol Hepatol. июнь 2019 г.; 4(6): 466 - 76. doi: 10.1016/S2468-1253(19)30042-1

111. Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, и др. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology. август 2020 г.; 72(2): 671 - 722. doi: 10.1002/hep.31065

112. Lampertico P, Agarwal K, Berg T, Buti M, Janssen HLA, Papatheodoridis G, и др. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol. август 2017 г.; 67(2): 370 - 98. doi: 10.1016/j.jhep.2017.03.021

113. Key recommendations. WHO Recommendations on the Diagnosis of HIV Infection in Infants and Children. World Health Organization 2010.

114. Reust CE. Evaluation of primary immunodeficiency disease in children. Am Fam Physician. 2013; 87: 773 - 8.

115. McAuley JB. Toxoplasmosis in Children. Pediatr Infect Dis J. февраль 2008 г.; 27(2): 161 - 2. doi: 10.1097/INF.0b013e3181658abb

116. Cascio A., Colomba C. Childhood Mediterranean visceral leishmaniasis//Le Infezioni in Medicina. - 2003. - Т. 11. - N. 1. - С. 5 - 10.

117. Howell MD, Davis AM. Management of Sepsis and Septic Shock. 2017 г.; 2.

118. Weiss SL, Peters MJ, Alhazzani W, Agus MSD, Flori HR, Inwald DP, и др. Surviving sepsis campaign international guidelines for the management of septic shock and sepsis-associated organ dysfunction in children. Intensive Care Med. февраль 2020 г.; 46(S1): 10 - 67. doi: 10.1007/s00134-019-05878-6

119. Рисунок 93 F, Рисунок 94 G, Comba A, Abbasguliyev H, Uyar NY, Рисунок 95 AG. Fecal calprotectin in children with familial Mediterranean fever in the attack-free period. Pediatr Int. ноябрь 2019 г.; 61(11): 1140 - 5. doi: 10.1111/ped.13995

120. Asan G, Derin ME, Рисунок 96 HO, Bayram M, Рисунок 97 M, Рисунок 98 A. Can Calprotectin Show Subclinical Inflammation in Familial Mediterranean Fever Patients? J Korean Med Sci. 2020 г.; 35(10): e63. doi: 10.3346/jkms.2020.35.e63

121. Hudgins K. Porphyria: A Rare, Complicated, and Misdiagnosed Disease. Crit Care Nurs Q. апрель 2019 г.; 42(2): 192 - 7. doi: 10.1097/CNQ.0000000000000253

122. Baresic M, Karanovic B, Coen Herak D, et al. Misleading symptoms of hereditary angioedema type II mimicking familial mediterranean fever. Acta Reumatol Port 2020; 45: 143 - 6.

123. Kazandjieva J, Christoff G. Angioedema as a systemic disease. Clin Dermatol. ноябрь 2019 г.; 37(6): 636 - 43. doi: 10.1016/j.clindermatol.2019.07.035

124. Ziegeler K, Eshed I, Diekhoff T, Hermann KG. Imaging of Joints and Bones in Autoinflammation. J Clin Med. 17 декабрь 2020 г.; 9(12): 4074. doi: 10.3390/jcm9124074

125. Ishak GE, Khoury NJ, Birjawi GA, El-Zein YR, Naffaa LN, Haddad MC. Imaging findings of familial Mediterranean fever. Clin Imaging. май 2006 г.; 30(3): 153 - 9. doi: 10.1016/j.clinimag.2005.07.002

126. Aharoni D, Hiller N, Hadas-Halpern I. Familial Mediterranean fever: abdominal imaging findings in 139 patients and review of the literature. Abdom Imaging. март 2000 г.; 25(3): 297 - 300. doi: 10.1007/s002610000006

127. Kriulin IA, Alexeeva EI, Dvoryakovskaya TM, Bursagova BI, Savostyanov KV, Zhurkova NV, и др. Cryopyrin-Associated Periodic Syndrome (CAPS) Caused by c.943A>G Variant of NLRP3 Gene: Clinical Case. Curr Pediatr. 26 ноябрь 2019 г.; 18(4): 270 - 6. doi: 10.15690/vsp.v18i4.2044

128. Turner D, Ruemmele FM, Orlanski-Meyer E, Griffiths AM, de Carpi JM, Bronsky J, и др. Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care - An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. август 2018 г.; 67(2): 257 - 91. doi: 10.1097/MPG.0000000000002035

129. Sierra D, Wood M, Kolli S, Felipez LM. Pediatric Gastritis, Gastropathy, and Peptic Ulcer Disease. Pediatr Rev. 1 ноябрь 2018 г.; 39(11): 542 - 9. doi: 10.1542/pir.2017-0234

130. Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, и др. Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016). J Pediatr Gastroenterol Nutr. июнь 2017 г.; 64(6): 991 - 1003. doi: 10.1097/MPG.0000000000001594

131. Hijaz NM, Attard TM, Colombo JM, Mardis NJ, Friesen CA. Comparison of the use of wireless capsule endoscopy with magnetic resonance enterography in children with inflammatory bowel disease. World J Gastroenterol 2019; 25(28): 3808 - 3822. DOI: 10.3748/wjg.v25.i28.3808.

132. Рисунок 99 J., Pacho R., Albrecht P. MR enterography imaging of Crohn's disease in pediatric patients. Pol J Radiol, 2014; 79: 79 - 87 doi: 10.12659/PJR.889760.

133. Kopylov U, et al. Diagnostic yield of capsule endoscopy versus magnetic resonance enterography and small bowel contrast ultrasound in the evaluation of small bowel Crohn's disease: Systematic review and meta-analysis. Dig Liver Dis 2017; 49: 854 - 63.

134. Spada C., Riccioni M. E., Costamagna G. Patients with known small bowel stricture or with symptoms of small bowel obstructionsecondary to Crohn's disease should not perform video capsule endoscopy without being previously tested for small bowel patency//Am. J. Gastroenterol. 2007. Vol. 102. N 7. P. 1542 - 1543.

135. Ruemmele FM, Veres G, Kolho KL, Griffiths A, Levine A, Escher JC, и др. Consensus guidelines of ECCO/ESPGHAN on the medical management of pediatric Crohn's disease. J Crohns Colitis. 1 октябрь 2014 г.; 8(10): 1179 - 207. doi: 10.1016/j.crohns.2014.04.005

136. Canpolat M, Gumus H, Gunduz Z, Dusunsel R, Kumandas S, Bayram A, и др. Neurological Manifestations in Familial Mediterranean Fever: Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey. Neuropediatrics. 22 сентябрь 2016 г.; 48(02): 079 - 85. doi: 10.1055/s-0036-1593374

137. Zucker EJ, Lee EY, Restrepo R, Eisenberg RL. Hip Disorders in Children. Am J Roentgenol. декабрь 2013 г.; 201(6): W776-96. doi: 10.2214/AJR.13.10623

138. Olmedilla G, Undaondo C, Vasquez W, Rodriguez N. Metastatic Malignant Peritoneal Mesothelioma Mimicking an Autoinflammatory Syndrome in a 12-Year-Old Boy. Pediatr Dev Pathol. сентябрь 2021 г.; 24(5): 478 - 83. doi: 10.1177/10935266211008438

139. Fonseca MB, Gomes FHR, Valera ET, Pileggi GS, Gonfiantini PB, Gonfiantini MB, и др. Signs and symptoms of rheumatic diseases as first manifestation of pediatric cancer: diagnosis and prognosis implications. Rev Bras Reumatol Engl Ed. июль 2017 г.; 57(4): 330 - 7. doi: 10.1016/j.rbre.2017.01.007

140. Grebenyuk V. et al. Fever of unknown origin: case reports from routine clinical practice and a review//Klinicka Mikrobiologie a Infekcni Lekarstvi. - 2021. - Т. 27. - N. 4. - С. 148 - 157.

141. Li Q. et al. Quantifying the contribution of 18F-FDG PET to the diagnostic assessment of pediatric patients with fever of unknown origin: a systematic review and meta-analysis//Pediatric Radiology. - 2022. - С. 1 - 12.

142. Tantawy A. A. G., Ebeid F. S. E., k El Sherif N. H. Reversible Posterior Leukoencephalopathy Syndrome Complicating Therapy of Hodgkin Disease in A Child with Familial Mediterranean Fever: A Case Report//American Journal of Cancer Case Reports. - 2013. - Т. 1. - N. 1. - С. 8 - 15.

143. Erbis G, Schmidt K, Hansmann S, Sergiichuk T, Michler C, Kuemmerle-Deschner JB, и др. Living with autoinflammatory diseases: identifying unmet needs of children, adolescents and adults. Pediatr Rheumatol. декабрь 2018 г.; 16(1): 81. doi: 10.1186/s12969-018-0300-7

144. Рисунок 100 K, Trieschmann U, Leister N. Рисунок 101 und Analgosedierung Рисунок 102 diagnostische Eingriffe bei Kindern. AINS - Рисунок 103 Intensivmed Notfallmedizin Schmerzther. июль 2023 г.; 58(07/08): 409 - 20. doi: 10.1055/a-1925-7009

145. Janssen NM, Karnad DR, Guntupalli KK. Rheumatologic diseases in the intensive care unit: epidemiology, clinical approach, management, and outcome. Crit Care Clin. октябрь 2002 г.; 18(4): 729 - 48. doi: 10.1016/S0749-0704(02)00025-8

146. Dumas G, Arabi YM, Bartz R, Ranzani O, Scheibe F, Darmon M, и др. Diagnosis and management of autoimmune diseases in the ICU. Intensive Care Med. январь 2024 г.; 50(1): 17 - 35. doi: 10.1007/s00134-023-07266-7

147. Cortis E, Insalaco A. Macrophage activation syndrome in juvenile idiopathic arthritis. Acta Paediatr. июль 2006 г.; 95(S452): 38 - 41. doi: 10.1111/j.1651-2227.2006.tb02414.x

148. Ravelli A, Рисунок 104 S, Minoia F, Martini A, Cron RQ. Macrophage Activation Syndrome. Hematol Oncol Clin North Am. октябрь 2015 г.; 29(5): 927 - 41. doi: 10.1016/j.hoc.2015.06.010

149. Henderson LA, Cron RQ. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management. Pediatr Drugs. февраль 2020 г.; 22(1): 29 - 44. doi: 10.1007/s40272-019-00367-1

150. Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, и др. Interleukin-1 Receptor Blockade Is Associated With Reduced Mortality in Sepsis Patients With Features of Macrophage Activation Syndrome: Reanalysis of a Prior Phase III Trial*. Crit Care Med. февраль 2016 г.; 44(2): 275 - 81. doi: 10.1097/CCM.0000000000001402

151. Hines MR, von Bahr Greenwood T, Beutel G, Beutel K, Hays JA, Horne A, и др. Consensus-Based Guidelines for the Recognition, Diagnosis, and Management of Hemophagocytic Lymphohistiocytosis in Critically Ill Children and Adults. Crit Care Med. май 2022 г.; 50(5): 860 - 72. doi: 10.1097/CCM.0000000000005361

152. Рисунок 105 T, Tse SML, Schneider R, Ngan B, Silverman ED. Macrophage activation syndrome as the presenting manifestation of rheumatic diseases in childhood. J Pediatr. май 2006 г.; 148(5): 683 - 6. doi: 10.1016/j.jpeds.2005.12.070

153. Lehmberg K, Pink I, Eulenburg C, Beutel K, Maul-Pavicic A, Janka G. Differentiating Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis from Other Forms of Hemophagocytic Lymphohistiocytosis. J Pediatr. июнь 2013 г.; 162(6): 1245 - 51. doi: 10.1016/j.jpeds.2012.11.081

154. Yokoyama T, Shimizu M, Ikeno I, Hashida Y, Fujita S, Shimura S, и др. A case of systemic-onset juvenile idiopathic arthritis complicated with sepsis - Usefulness of cytokine profile for the differentiation between macrophage activation syndrome and sepsis-. Jpn J Clin Immunol. 2011 г.; 34(2): 105 - 11. doi: 10.2177/jsci.34.105

155. Rigante D, Emmi G, Fastiggi M, Silvestri E, Cantarini L. Macrophage activation syndrome in the course of monogenic autoinflammatory disorders. Clin Rheumatol. август 2015 г.; 34(8): 1333 - 9. doi: 10.1007/s10067-015-2923-0

156. Ravelli A, Рисунок 106 S, Minoia F, Martini A, Cron RQ. Macrophage Activation Syndrome. Hematol Oncol Clin North Am. октябрь 2015 г.; 29(5): 927 - 41. doi: 10.1016/j.hoc.2015.06.010

157. Chen TY, Hsu MH, Kuo HC, Sheen JM, Cheng MC, Lin YJ. Outcome analysis of pediatric hemophagocytic lymphohistiocytosis. J Formos Med Assoc. январь 2021 г.; 120(1): 172 - 9. doi: 10.1016/j.jfma.2020.03.025

158. Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M, и др. The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS). Ann Rheum Dis. октябрь 2023 г.; 82(10): 1271 - 85. doi: 10.1136/ard-2023-224123

159. Bagri NK, Gupta L, Sen ES, Ramanan AV. Macrophage Activation Syndrome in Children: Diagnosis and Management. Indian Pediatr. декабрь 2021 г.; 58(12): 1155 - 61. doi: 10.1007/s13312-021-2399-8

160. Valade S, Mariotte E, Azoulay E. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome. Crit Care Clin. апрель 2020 г.; 36(2): 415 - 26. doi: 10.1016/j.ccc.2019.12.004

161. Рисунок 107 S, Minoia F, Cron RQ, Ravelli A. Macrophage Activation Syndrome. B: Sawhney S, Aggarwal A, редакторы. Pediatric Rheumatology [Интернет]. Singapore: Springer Singapore; 2017 [цитируется по 2 октябрь 2022 г.]. с. 275 - 92. Доступно на: http://link.springer.com/10.1007/978-981-10-1750-6_22 doi: 10.1007/978-981-10-1750-6_22

162. Yuan W-H, Liu H-C, Zeng L-K, et al. [Change of Thrombelastography in Children's DIC and Analysis of Its Sensitivity and Specificity for Diagnosis of DIC]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2017; 25: 847 - 52. doi: 10.7534/j.issn.1009-2137.2017.03.039.

163. Law C, Raffini L. A Guide to the Use of Anticoagulant Drugs in Children. Pediatr Drugs. апрель 2015 г.; 17(2): 105 - 14. doi: 10.1007/s40272-015-0120-x

164. kliniko-diagnosticheskie-aspekty-nachalnoy-stadii-yuvenilnogo-psoriaticheskogo-artrita.

165. Long S.S., Pickering L.K., Prober C.G. Principles and practice of pediatric infectious diseases. - 2023.

166. Ansuini V, Rigante D, Esposito S. Debate around infection-dependent hemophagocytic syndrome in paediatrics. BMC Infect Dis. декабрь 2013 г.; 13(1): 15. doi: 10.1186/1471-2334-13-15

167. D'Errico MM, Cuoco F, Biancardi C, Torcoletti M, Filocamo G, Corona F. YIM-P58. Macrophage activation syndrome: the role of infectious triggers. Pediatr Rheumatol. сентябрь 2014 г.; 12(S1): Y5, 1546-0096-12-S1-Y5. doi: 10.1186/1546-0096-12-S1-Y5

168. Eloseily EM, Cron RQ. Macrophage Activation Syndrome. In: Ragab G, Atkinson TP, Stoll ML, eds. The Microbiome in Rheumatic Diseases and Infection. Cham: Springer International Publishing 2018: 151 - 82.

169. Long S.S., Pickering L.K., Prober C.G. Principles and practice of pediatric infectious diseases. - 2023.

170. Xu D, Li S, Chen Z, Du L. Detection of Mycoplasma pneumoniae in different respiratory specimens. Eur J Pediatr. июль 2011 г.; 170(7): 851 - 8. doi: 10.1007/s00431-010-1360-y

171. Copete AR, Vera C, Herrera M, Aguilar YA, Rueda ZV, Рисунок 108 LA. Mycoplasma pneumoniae in Children With and Without Community-acquired Pneumonia. What do PCR and Serology Say? Pediatr Infect Dis J. июль 2020 г.; 39(7): e104-8. doi: 10.1097/INF.0000000000002636

172. Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Рисунок 109 R, и др. Diagnosis of Mycoplasma pneumoniae Pneumonia in Children. J Clin Microbiol. ноябрь 1998 г.; 36(11): 3155 - 9. doi: 10.1128/JCM.36.11.3155-3159.1998

173. Department of Microbiology, Maulana Azad Medical College, India, Kumar S, Kumar S, Department of Pathology, Government Medical College & Hospital, India. Mycoplasma Pneumoniae as a Causative Agent of Community-Acquired Lower Respiratory Tract Infections in Children. Ann Pediatr Child Health. 18 декабрь 2023 г.; 11(5): 1 - 4. doi: 10.47739/2373-9312.pediatrics.1325

174. Blanche S, Caniglia M, Fischer A, Griscelli C. Epstein-Barr Virus-Associated Hemophagocytic Syndrome: Clinical Presentation and Treatment. Pediatr Hematol Oncol. январь 1989 г.; 6(3): 233 - 5. doi: 10.3109/08880018909034292

175. for the Paediatric Rheumatology International Trials Organisation (PRINTO), Giancane G, Swart JF, Castagnola E, Groll AH, Horneff G, и др. Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee. Arthritis Res Ther. декабрь 2020 г.; 22(1): 71. doi: 10.1186/s13075-020-02167-2

176. Zeng HS, Xiong XY, Wei YD, Wang HW, Luo XP. Macrophage activation syndrome in 13 children with systemic-onset juvenile idiopathic arthritis. World J Pediatr. май 2008 г.; 4(2): 97 - 101. doi: 10.1007/s12519-008-0018-6

177. Brisse E, Matthys P, Wouters CH. Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options. Br J Haematol. июль 2016 г.; 174(2): 175 - 87. doi: 10.1111/bjh.14144

178. Nadimpalli S, Foca M, Satwani P, Sulis ML, Constantinescu A, Saiman L. Diagnostic yield of bronchoalveolar lavage in immunocompromised children with malignant and non-malignant disorders. Pediatr Pulmonol. июнь 2017 г.; 52(6): 820 - 6. doi: 10.1002/ppul.23644

179. De Blic J, Midulla F, Barbato A, Clement A, Dab I, Eber E, и др. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J. 1 январь 2000 г.; 15(1): 217 - 31. doi: 10.1183/09031936.00.15121700

180. Amanati A, Karimi A, Fahimzad A, Shamshiri AR, Fallah F, Mahdavi A, и др. Prevalence of Human Herpes Viruses in Bronchoalveolar Lavage of Critically Ill Children Undergoing Mechanical Ventilation at a Pediatric Intensive Care Unit. Arch Pediatr Infect Dis. 18 март 2018 г.; 6(2). doi: 10.5812/pedinfect.12685

181. Wong JCP, Hon KLE, Leung KKY, Qian S, Leung AKC. Diagnostic Yield of Bronchoalveolar Lavage in Immunocompromised Children. J Trop Pediatr. 29 январь 2021 г.; 67(1): fmaa131. doi: 10.1093/tropej/fmaa131

182. Varadaraju S, Khandelwal P, Sankar J, Hari P. Multiple opportunistic infection-associated hemophagocytic lymphohistiocytosis in nephrotic syndrome: A case report. J Pediatr Crit Care. ноябрь 2021 г.; 8(6): 295 - 8. doi: 10.4103/jpcc.jpcc_64_21

183. Lachant DJ, Croft DP, McGrane Minton H, Hardy DJ, Prasad P, Kottmann RM. The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients. Respir Med. декабрь 2018 г.; 145: 35 - 40. doi: 10.1016/j.rmed.2018.10.021

184. Рисунок 110 S, Bayram Рисунок 111 S. Investigation of Pneumocystis jirovecii Pneumonia and Colonization in Iatrogenically Immunosuppressed and Immunocompetent Patients. Mikrobiyol Bul. 24 апрель 2015 г.; 49(2): 221 - 30. doi: 10.5578/mb.9344

185. Eroglu-Ertugrul NG, Yalcin E, Oguz B, Ocal T, Kuskonmaz B, Emiralioglu N, и др. The value of flexible bronchoscopy in pulmonary infections of immunosuppressed children. Clin Respir J. февраль 2020 г.; 14(2): 78 - 84. doi: 10.1111/crj.13103

186. Gonski K, Cohn R, Widger J, McMullan B. Utility of bronchoscopy in immunocompromised paediatric patients: Systematic review. Paediatr Respir Rev. апрель 2020 г.; 34: 24 - 34. doi: 10.1016/j.prrv.2020.02.003

187. Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 13 август 2021 г.; 22(12): 1579 - 92. doi: 10.1080/14656566.2021.1915989

188. Morris A, Norris KA. Colonization by Pneumocystis jirovecii and Its Role in Disease. Clin Microbiol Rev. апрель 2012 г.; 25(2): 297 - 317. doi: 10.1128/CMR.00013-12

189. White PL, Price JS, Backx M. Pneumocystis jirovecii Pneumonia: Epidemiology, Clinical Manifestation and Diagnosis. Curr Fungal Infect Rep. декабрь 2019 г.; 13(4): 260 - 73. doi: 10.1007/s12281-019-00349-3

190. Рисунок 112 M, Рисунок 113 M, Рисунок 114 J. Pneumocystis pneumonia in a child with sojia. Pediatr Rheumatol. сентябрь 2014 г.; 12(S1): P225, 1546-0096-12-S1-P225. doi: 10.1186/1546-0096-12-S1-P225

191. Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, и др. Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. декабрь 2019 г.; 78(12): 1722 - 31. doi: 10.1136/annrheumdis-2019-216040

192. Rayment JH, Narang I. Pulmonary Aspergillosis in a Previously Healthy 13-Year-Old Boy. Can Respir J. 2016 г.; 2016: 1 - 3. doi: 10.1155/2016/4575942

193. De Mol M, De Jongste JC, Van Westreenen M, Merkus PJFM, De Vries AHC, Hop WCJ, и др. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan. Pediatr Pulmonol. август 2013 г.; 48(8): 789 - 96. doi: 10.1002/ppul.22670

194. Limper M, de Kruif MD, Duits AJ, Brandjes DPM, van Gorp ECM. The diagnostic role of Procalcitonin and other biomarkers in discriminating infectious from non-infectious fever. J Infect. июнь 2010 г.; 60(6): 409 - 16. doi: 10.1016/j.jinf.2010.03.016

195. Zhao M, Guan Y, Lin J, Qiu Y, Zhao S, Duan M. Acute kidney injury in critical care: complications of hemophagocytic lymphohistiocytosis. Front Immunol. 18 июнь 2024 г.; 15: 1396124. doi: 10.3389/fimmu.2024.1396124

196. Fitzgerald NE, MacClain KL. Imaging characteristics of hemophagocytic lymphohistiocytosis. Pediatr Radiol. июнь 2003 г.; 33(6): 392 - 401. doi: 10.1007/s00247-003-0894-9

197. Schmidt MH, Sung L, Shuckett BM. Hemophagocytic Lymphohistiocytosis in Children: Abdominal US Findings within 1 Week of Presentation. Radiology. март 2004 г.; 230(3): 685 - 9. doi: 10.1148/radiol.2303030223

198. Chinnici A, Beneforti L, Pegoraro F, Trambusti I, Tondo A, Favre C, и др. Approaching hemophagocytic lymphohistiocytosis. Front Immunol. 22 июнь 2023 г.; 14: 1210041. doi: 10.3389/fimmu.2023.1210041

199. Malik P, Antonini L, Mannam P, Aboobacker FN, Merve A, Gilmour K, и др. MRI Patterns in Pediatric CNS Hemophagocytic Lymphohistiocytosis. Am J Neuroradiol. ноябрь 2021 г.; 42(11): 2077 - 85. doi: 10.3174/ajnr.A7292

200. Shieh AC, Guler E, Smith DA, Tirumani SH, Beck RC, Ramaiya NH. Hemophagocytic Lymphohistiocytosis: A Primer for Radiologists. Am J Roentgenol. январь 2020 г.; 214(1): W11-9. doi: 10.2214/AJR.19.21788

201. Henderson LA, Cron RQ. Macrophage Activation Syndrome and Secondary Hemophagocytic Lymphohistiocytosis in Childhood Inflammatory Disorders: Diagnosis and Management. Pediatr Drugs. февраль 2020 г.; 22(1): 29 - 44. doi: 10.1007/s40272-019-00367-1

202. Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheumatol. май 2007 г.; 34(5): 1133 - 8. PubMed PMID: 17343315.

203. Hur M, Kim YC, Lee KM, Kim KN. Macrophage Activation Syndrome in a Child with Systemic Juvenile Rheumatoid Arthritis. J Korean Med Sci. 2005 г.; 20(4): 695. doi: 10.3346/jkms.2005.20.4.695

204. Shekarchian F, Abadi MKA, Shariati MM. Clinical approach to a child with hemophagocytic lymphohistiocytosis and bilateral optic nerve head infiltration: A case report and brief literature review. Clin Case Rep. октябрь 2023 г.; 11(10): e7999. doi: 10.1002/ccr3.7999

205. Wang L, Suo L, Kou F, Zhang Y, Li M, Wang H, и др. Ocular Phenotypes in Patients With Hemophagocytic Lymphohistiocytosis: A Retrospective Analysis in a Single Center Over 7 Years. Am J Ophthalmol. сентябрь 2023 г.; 253: 119 - 31. doi: 10.1016/j.ajo.2023.05.011

206. Рисунок 115 M. et al. Atypical eye manifestation in macrophage activation syndrome complicating systemic juvenile idiopathic arthritis//Alergia, Asma e Рисунок 116 Рисунок 117. - 2020. - Т. 29. - N. 2. - С. 66 - 70.

207. Ravelli A, Minoia F, Рисунок 118 S, Horne A, Bovis F, Pistorio A, и др. 2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis. Ann Rheum Dis. март 2016 г.; 75(3): 481 - 9. doi: 10.1136/annrheumdis-2015-208982

208. Криулин И.А., Алексеева Е.И., Шилькрот И.Ю., Дворяковская Т.М. Вторичный гемофагоцитарный синдром: прогностическая модель и ранние маркеры развития у пациентов с системным ювенильным идиопатическим артритом. Результаты когортного ретроспективного исследования. Вопросы практической педиатрии. 2022; 17(6): 17 - 24. DOI: 10.20953/1817-7646-2022-6-17-24

209. Cantini F, Nannini C, Niccoli L, Iannone F, Delogu G, Garlaschi G, и др. Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice. Autoimmun Rev. июнь 2015 г.; 14(6): 503 - 9. doi: 10.1016/j.autrev.2015.01.011

210. Handa R, Upadhyaya S, Kapoor S, Jois R, Pandey BD, Bhatnagar AK, и др. Tuberculosis and biologics in rheumatology: A special situation. Int J Rheum Dis. октябрь 2017 г.; 20(10): 1313 - 25. doi: 10.1111/1756-185X.13129

211. Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. апрель 2014 г.; 13(4 - 5): 546 - 9. doi: 10.1016/j.autrev.2014.01.005

212. Рисунок 119 M, Рисунок 120 M, Рисунок 121 J. Pneumocystis pneumonia in a child with sojia. Pediatr Rheumatol. сентябрь 2014 г.; 12(S1): P225, 1546-0096-12-S1-P225. doi: 10.1186/1546-0096-12-S1-P225

213. Sulieman SE, Metjian TA, Zaoutis TE, Fisher BT. Pneumocystis Pneumonia: Epidemiology and Options for Prophylaxis in Non-HIV Immunocompromised Pediatric Patients. Curr Fungal Infect Rep. март 2014 г.; 8(1): 45 - 55. doi: 10.1007/s12281-014-0177-y

214. Bateman M, Oladele R, Kolls JK. Diagnosing Pneumocystis jirovecii pneumonia: A review of current methods and novel approaches. Med Mycol. 10 ноябрь 2020 г.; 58(8): 1015 - 28. doi: 10.1093/mmy/myaa024

215. Park JW, Curtis JR, Kim MJ, Lee H, Song YW, Lee EB. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole. Arthritis Res Ther. декабрь 2019 г.; 21(1): 207. doi: 10.1186/s13075-019-1996-6

216. Рисунок 122 J, Рисунок 123 S, Рисунок 124 MT, Frick MA, Рисунок 125 J, Pujol-Jover M, и др. Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades. Enfermedades Infecc Microbiol Clinica. март 2020 г.; 38(3): 111 - 8. doi: 10.1016/j.eimc.2019.05.005

217. Eroglu-Ertugrul NG, Yalcin E, Oguz B, Ocal T, Kuskonmaz B, Emiralioglu N, и др. The value of flexible bronchoscopy in pulmonary infections of immunosuppressed children. Clin Respir J. февраль 2020 г.; 14(2): 78 - 84. doi: 10.1111/crj.13103

218. Gonski K, Cohn R, Widger J, McMullan B. Utility of bronchoscopy in immunocompromised paediatric patients: Systematic review. Paediatr Respir Rev. апрель 2020 г.; 34: 24 - 34. doi: 10.1016/j.prrv.2020.02.003

219. Рисунок 126 S, Bayram Рисунок 127 S. Investigation of Pneumocystis jirovecii Pneumonia and Colonization in Iatrogenically Immunosuppressed and Immunocompetent Patients. Mikrobiyol Bul. 24 апрель 2015 г.; 49(2): 221 - 30. doi: 10.5578/mb.9344

220. Lachant DJ, Croft DP, McGrane Minton H, Hardy DJ, Prasad P, Kottmann RM. The clinical impact of pneumocystis and viral PCR testing on bronchoalveolar lavage in immunosuppressed patients. Respir Med. декабрь 2018 г.; 145: 35 - 40. doi: 10.1016/j.rmed.2018.10.021

221. Ramos JT, Romero CA, Belda S, et al. Clinical practice update of antifungal prophylaxis in immunocompromised children. Rev Espanola Quimioter Publicacion Of Soc Espanola Quimioter 2019; 32: 410 - 25.

222. Tragiannidis A, Kyriakidis I, Zundorf I, Groll AH. Invasive fungal infections in pediatric patients treated with tumor necrosis alpha Рисунок 128 inhibitors. Mycoses. апрель 2017 г.; 60(4): 222 - 9. doi: 10.1111/myc.12576

223. Behringer J, Ryan M, Miller M, Jaju A. Magnetic resonance imaging findings in a patient with cryopyrin-associated periodic syndrome: A rare hereditary multi-system inflammatory disorder. Neuroradiol J. декабрь 2019 г.; 32(6): 420 - 5. doi: 10.1177/1971400919863712

224. Plosa EJ, Esbenshade JC, Fuller MP, Weitkamp JH. Cytomegalovirus Infection. Pediatr Rev. 1 апрель 2012 г.; 33(4): 156 - 63. doi: 10.1542/pir.33.4.156

225. Adler SP, Marshall B. Cytomegalovirus Infections. 11.

226. Noguera-Julian A, Рисунок 129 J, Brinkmann F, Basu Roy R, Bilogortseva O, Buettcher M, и др. Tuberculosis Disease in Children and Adolescents on Therapy With Antitumor Necrosis Factor-Agents: A Collaborative, Multicenter Paediatric Tuberculosis Network European Trials Group (ptbnet) Study. Clin Infect Dis. 17 декабрь 2020 г.; 71(10): 2561 - 9. doi: 10.1093/cid/ciz1138

227. Vilibic-Cavlek T, Ljubin-Sternak S, Kos L, Mlinaric-Galinovic G. The role of IgG avidity determination in diagnosis of Epstein-Barr virus infection in immunocompetent and immunocompromised patients. Acta Microbiol Immunol Hung. 1 декабрь 2011 г.; 58(4): 351 - 7. doi: 10.1556/amicr.58.2011.4.10

228. Galindo-Zavala R, Bou-Torrent R, Рисунок 130 B, Рисунок 131 C, Palmou-Fontana N, Рисунок 132 B, и др. Expert panel consensus recommendations for diagnosis and treatment of secondary osteoporosis in children. Pediatr Rheumatol. декабрь 2020 г.; 18(1): 20. doi: 10.1186/s12969-020-0411-9

229. Buckley L, Guyatt G, Fink HA, Cannon M, Grossman J, Hansen KE, и др. 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis: ACR guideline for glucocorticoid-induced osteoporosis prevention and treatment. Arthritis Rheumatol. август 2017 г.; 69(8): 1521 - 37. doi: 10.1002/art.40137

230. Kisla Ekinci RM, Рисунок 133 S, Bisgin A, Cetin F, Tumgor G. The contribution of diet preference to the disease course in children with familial Mediterranean fever: a cross-sectional study. Reumatologia/Rheumatology. 2020 г.; 58(2): 81 - 6. doi: 10.5114/reum.2020.95361

231. Kazem Y, Zarouk WA, Hamed K, et al. The Effect of Anti-inflammatory Diet and Vitamin D Supplementation on the Amelioration of the Clinical Status and Cognitive functions of Familial Mediterranean Fever Patients. Kobe J Med Sci 2021; 66: E159-65.

232. Abad Рисунок 134, Andreu JL, Caracuel Ruiz Рисунок 135, Belmonte Serrano Рисунок 136, Рисунок 137 F, Moreno Muelas JV. Position Paper From the Spanish Society of Rheumatology on Biosimilar Drugs. Reumatol Рисунок 138 Engl Ed. сентябрь 2015 г.; 11(5): 269 - 78. doi: 10.1016/j.reumae.2015.03.012

233. Fc A. The Portuguese Society of Rheumatology position paper on the use of biosimilars - 2017 update. 2017.

234. Atzeni F, Sebastiani M, Ricci C, et al. Position paper of Italian rheumatologists on the use of biosimilar drugs.

235. Sherman JM, Sood SK. Current challenges in the diagnosis and management of fever. Curr Opin Pediatr. июнь 2012 г.; 24(3): 400 - 6. doi: 10.1097/MOP.0b013e32835333e3

236. ter Haar N, Lachmann H, Рисунок 139 S, Woo P, Uziel Y, Modesto C, и др. Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review. Ann Rheum Dis. май 2013 г.; 72(5): 678 - 85. doi: 10.1136/annrheumdis-2011-201268

237. Ozen S, Bilginer Y. A clinical guide to autoinflammatory diseases: familial Mediterranean fever and next-of-kin. Nat Rev Rheumatol. март 2014 г.; 10(3): 135 - 47. doi: 10.1038/nrrheum.2013.174

238. Рисунок 140 M., Karadag S. G., Ayaz N. A. Corticosteroid-resistant anakinra-responsive protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever//Northern Clinics of Istanbul. - 2020. - Т. 7. - N. 1. - С. 78.

239. Рисунок 141 O. et al. Cerebral vasculitis in a child with Henoch-Schonlein purpura and familial Mediterranean fever//Clinical rheumatology. - 2007. - Т. 26. - N. 10. - С. 1729 - 1732.

240. Рисунок 142 S. A. et al. Polyarteritis nodosa in a case of familial Mediterranean fever//Pediatric Nephrology. - 2004. - Т. 19. - N. 5. - С. 536 - 538.

241. Рисунок 143 K., Рисунок 144 M. Protracted febrile myalgia syndrome as the first manifestation of familial Mediterranean fever in children: case-based review//Rheumatology International. - 2021. - Т. 41. - N. 1. - С. 213 - 218.

242. Ozturk MA, Kanbay M, Kasapoglu B, et al. Therapeutic approach to familial Mediterranean fever: a review update. Clin Exp Rheumatol 2011; 29: S77 - 86.

243. Pankow A, Feist E, Baumann U, Kirschstein M, Burmester GR, Wagner AD. Was ist gesichert in der Therapie von autoinflammatorischen Fiebererkrankungen? Internist. декабрь 2021 г.; 62(12): 1280 - 9. doi: 10.1007/s00108-021-01220-9

244. Sarikaya S., Рисунок 145., Рисунок 146 E. Spondylitis and arthritis in familial Mediterranean fever//Archives of Rheumatology. - 2012. - Т. 27. - N. 4. - С. 241 - 247.

245. Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, и др. Colchicine Use in Children and Adolescents With Familial Mediterranean Fever: Literature Review and Consensus Statement. Pediatrics. 1 февраль 2007 г.; 119(2): e474-83. doi: 10.1542/peds.2006-1434

246. Demirkaya E, Erer B, Ozen S, Ben-Chetrit E. Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review. Rheumatol Int. март 2016 г.; 36(3): 325 - 31. doi: 10.1007/s00296-015-3408-9

247. 247. Padeh S, Gerstein M, Berkun Y. Colchicine is a Safe Drug in Children with Familial Mediterranean Fever. J Pediatr. декабрь 2012 г.; 161(6): 1142 - 6. doi: 10.1016/j.jpeds.2012.05.047

248. Ozen S, Kone-Paut I, Рисунок 147 A. Colchicine resistance and intolerance in familial mediterranean fever: Definition, causes, and alternative treatments. Semin Arthritis Rheum. август 2017 г.; 47(1): 115 - 20. doi: 10.1016/j.semarthrit.2017.03.006

249. Tufan A, Lachmann HJ. Familial Mediterranean fever, from pathogenesis to treatment: a contemporary review. Turk J Med Sci. 3 ноябрь 2020 г.; 50(7): 1591 - 610. doi: 10.3906/sag-2008-11

250. Kuemmerle-Deschner JB, Gautam R, George AT, Raza S, Lomax KG, Hur P. A systematic literature review of efficacy, effectiveness and safety of biologic therapies for treatment of familial Mediterranean fever. Rheumatology. 1 октябрь 2020 г.; 59(10): 2711 - 24. doi: 10.1093/rheumatology/keaa205

251. Hentgen V, Vinit C, Fayand A, Georgin-Lavialle S. The Use of Interleukine-1 Inhibitors in Familial Mediterranean Fever Patients: A Narrative Review. Front Immunol. 28 май 2020 г.; 11: 971. doi: 10.3389/fimmu.2020.00971

252. Mercan R, Turan A, Bitik B, Tufan A, Haznedaroglu S, Goker B. Rapid resolution of protracted febrile myalgia syndrome with anakinra: Report of two cases. Mod Rheumatol. 3 май 2016 г.; 26(3): 458 - 9. doi: 10.3109/14397595.2014.882221

253. Ruperto N, Murray KJ, Gerloni V, Wulffraat N, Feitosa De Oliveira SK, Falcini F, и др. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. Arthritis Rheum. июль 2004 г.; 50(7): 2191 - 201. doi: 10.1002/art.20288

254. Bakkaloglu SA, Aksu T, Goker B, Unlusoy A, Peru H, Fidan K, и др. Sulphasalazine treatment in protracted familial Mediterranean fever arthritis. Eur J Pediatr. август 2009 г.; 168(8): 1017 - 9. doi: 10.1007/s00431-008-0875-y

255. Рисунок 148 H. et al. Sacroiliitis in children and adolescents with familial Mediterranean fever//Advances in Rheumatology. - 2021. - Т. 61.

256. Langevitz P. et al. Seronegative spondyloarthropathy in familial Mediterranean fever//Seminars in arthritis and rheumatism. - WB Saunders, 1997. - Т. 27. - N. 2. - С. 67 - 72.

257. В Aydin F. et al. Sacroiliitis in children with familial Mediterranean fever//JCR: Journal of Clinical Rheumatology. - 2019. - Т. 25. - N. 2. - С. 69 - 73.

258. Yucel I. K. et al. Economic impact of juvenile idiopathic arthritis and familial Mediterranean fever//Rheumatology international. - 2012. - Т. 32. - N. 7. - С. 1955 - 1962.

259. Alexeeva E., Kozlova A., Valiyeva S., Bzarova T., Chomakhidze A., Isaeva K. New opportunities in treatment of juvenile ankylosing spondyloarthritis. Current Pediatrics. 2010; 9(2): 23 - 31.

260. On behalf of the Rheumatology Italian Study Group, Ferrara G, Mastrangelo G, Barone P, La Torre F, Martino S, и др. Methotrexate in juvenile idiopathic arthritis: advice and recommendations from the MARAJIA expert consensus meeting. Pediatr Rheumatol. декабрь 2018 г.; 16(1): 46. doi: 10.1186/s12969-018-0255-8

261. Woo P, Southwood TR, Prieur AM, Рисунок 149 CJ, Grainger J, David J, и др. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Arthritis Rheum. август 2000 г.; 43(8): 1849 - 57. doi: 10.1002/1529-0131(200008) 43: 8 < 1849:: AID-ANR22>3.0.CO; 2-F

262. Ozgocmen S, Akgul O. Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. Mod Rheumatol. декабрь 2011 г.; 21(6): 684 - 90. doi: 10.3109/s10165-011-0463-2

263. Guti rrez-Su rez R., Burgos-Vargas R. The use of methotrexate in children with rheumatic diseases//Clinical and Experimental Rheumatology-Incl Supplements. - 2010. - Т. 28. - N. 5. - С. S122.

264. Hunt PG, Rose CD, McIlvain-Simpson G, et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. J Rheumatol 1997; 24: 2230 - 2.

265. Colak S, Tekgoz E, Cinar M, Yilmaz S. The assessment of tocilizumab therapy on recurrent attacks of patients with familial Mediterranean fever: A retrospective study of 15 patients. Mod Rheumatol. 2 январь 2021 г.; 31(1): 223 - 5. doi: 10.1080/14397595.2019.1709258

266. Inui K, Sawa N, Suwabe T, Mizuno H, Yamanouchi M, Hiramatsu R, и др. Long term administration of tocilizumab improves renal amyloid A (AA) amyloidosis deposition in Familial Mediterranean fever. Mod Rheumatol Case Rep. 2 июль 2020 г.; 4(2): 310 - 1. doi: 10.1080/24725625.2020.1739193

267. Grevich S, Shenoi S. Update on the management of systemic juvenile idiopathic arthritis and role of IL-1 and IL-6 inhibition. Adolesc Health Med Ther. ноябрь 2017 г.; Volume 8: 125 - 35. doi: 10.2147/AHMT.S109495

268. Mitchell E, Jones G. Subcutaneous tocilizumab for the treatment of rheumatoid arthritis. Expert Rev Clin Immunol. февраль 2016 г.; 12(2): 103 - 14. doi: 10.1586/1744666X.2016.1127159

269. Koga T. et al. A Randomized, Double-Blind, Placebo-Controlled Phase III Trial On The Efficacy and Safety of Tocilizumab in Patients With Colchicine-Resistant or-Intolerant Familial Mediterranean Fever. - 2021.

270. Mulders-Manders C. M. et al. Systemic autoinflammatory diseases and Fever Syndromes. - 2020. - С. 135.

271. Brunner HI, Ruperto N, Tzaribachev N, Horneff G, Chasnyk VG, Panaviene V, и др. Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial. Ann Rheum Dis. январь 2018 г.; 77(1): 21-9. doi: 10.1136/annrheumdis-2016-210456

272. Cherqaoui B. et al. Boundaries between familial Mediterranean fever and juvenile spondyloarthritis: Analysis of three French retrospective cohorts//Joint Bone Spine. - 2018. - Т. 85. - N. 6. - С. 733 - 739.

273. Akgul O. et al. Efficacy and safety of biologic treatments in Familial Mediterranean Fever//The American Journal of the Medical Sciences. - 2013. - Т. 346. - N. 2. - С. 137 - 141.

274. Avar-Aydin P. O. et al. Ocular inflammatory diseases in children with familial Mediterranean fever: a true association or a coincidence?//International Ophthalmology. - 2022. - Т. 42. - N. 4. - С. 1249 - 1257.

275. Scott C., Slamang W. Biologics in childhood rheumatic disorders//Current Allergy & Clinical Immunology. - 2018. - Т. 31. - N. 4. - С. 206 - 211.

276. Cabrera N. et al. Safety of biological agents in paediatric rheumatic diseases: a real-life multicenter retrospective study using the JIRcohorte database//Joint Bone Spine. - 2019. - Т. 86. - N. 3. - С. 343 - 350.

277. Рисунок 150 K saarslan A. et al. Evaluation of familial Mediterranean fever patients concomitant with juvenile spondyloarthropathy//Modern rheumatology. - 2021. - Т. 31. - N. 3. - С. 718 - 724.

278. ter Haar NM, van Delft ALJ, Annink KV, van Stel H, Al-Mayouf SM, Amaryan G, и др. In silico validation of the Autoinflammatory Disease Damage Index. Ann Rheum Dis. ноябрь 2018 г.; 77(11): 1599 - 605. doi: 10.1136/annrheumdis-2018-213725

279. Pras E, Livneh A, Balow JE, Pras E, Kastner DL, Pras M, и др. Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 13 январь 1998 г.; 75(2): 216 - 9. doi: 10.1002/(SICI) 1096-8628(19980113) 75: 2<216::AID-AJMG20>3.0.CO; 2-R

280. Babaoglu H, Armagan B, Bodakci E, et al. Factors associated with damage in patients with familial Mediterranean fever. Clin Exp Rheumatol 2020; 38 Suppl 127: 42 - 8.

281. Terreri MTRA, Bernardo WM, Len CA, da Silva CAA, de Magalhaes CMR, Sacchetti SB, и др. Guidelines for the management and treatment of periodic fever syndromes. Rev Bras Reumatol Engl Ed. январь 2016 г.; 56(1): 44 - 51. doi: 10.1016/j.rbre.2015.08.020

282. Salugina SO, Fedorov ES, Kuzmina NN. Current approaches to diagnosis, treatment, and monitoring in patients with cryopyrin-associated periodic syndromes (CAPS). Mod Rheumatol J 2016; 10: 4 - 11. doi: 10.14412/1996-7012-2016-2-4-11.

283. ter Haar NM, Oswald M, Jeyaratnam J, Anton J, Barron KS, Brogan PA, и др. Recommendations for the management of autoinflammatory diseases. Ann Rheum Dis. сентябрь 2015 г.; 74(9): 1636 - 44. doi: 10.1136/annrheumdis-2015-207546

284. Henter JI. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 18 сентябрь 2002 г.; 100(7): 2367 - 73. doi: 10.1182/blood-2002-01-0172

285. Stephan JL. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. Rheumatology. 1 ноябрь 2001 г.; 40(11): 1285 - 92. doi: 10.1093/rheumatology/40.11.1285

286. I.A.Kriulin IAK, Kriulin IA, National Medical Research Center for Children's Health, Moscow, Russian Federation, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation, Alexeeva EI, National Medical Research Center for Children's Health, Moscow, Russian Federation, и др. Hemophagocytic lymphohistiocytosis: mechanisms of development, clinical manifestations, and treatments. Vopr Prakt Pediatr. 2021 г.; 16(6): 94 - 102. doi: 10.20953/1817-7646-2021-6-94-102

287. Grom AA, Horne A, De Benedetti F. Macrophage activation syndrome in the era of biologic therapy. Nat Rev Rheumatol. май 2016 г.; 12(5): 259 - 68. doi: 10.1038/nrrheum.2015.179

288. Henter JI. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 18 сентябрь 2002 г.; 100(7): 2367 - 73. doi: 10.1182/blood-2002-01-0172

289. I.A. Kriulin IAK, Kriulin IA, National Medical Research Center for Children's Health, Moscow, Russian Federation, I.M.Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russian Federation, Alexeeva EI, National Medical Research Center for Children's Health, Moscow, Russian Federation, и др. Hemophagocytic lymphohistiocytosis: mechanisms of development, clinical manifestations, and treatments. Vopr Prakt Pediatr. 2021 г.; 16(6): 94 - 102. doi: 10.20953/1817-7646-2021-6-94-102

290. Bagri NK, Gupta L, Sen ES, Ramanan AV. Macrophage Activation Syndrome in Children: Diagnosis and Management. Indian Pediatr. декабрь 2021 г.; 58(12): 1155 - 61. doi: 10.1007/s13312-021-2399-8

291. Zhang H qi, Yang SW, Fu YC, Chen MC, Yang CH, Yang MH, и др. Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis. Immunol Res. октябрь 2022 г.; 70(5): 566 - 77. doi: 10.1007/s12026-022-09285-w

292. Pelewicz K, Рисунок 151 P. Glucocorticoid Withdrawal-An Overview on When and How to Diagnose Adrenal Insufficiency in Clinical Practice. Diagnostics. 20 апрель 2021 г.; 11(4): 728. doi: 10.3390/diagnostics11040728

293. Alves C, Robazzi TCV, Mendon&ccedil; a M. Withdrawal from glucocorticosteroid therapy: clinical practice recommendations. J Pediatr (Rio J). 30 май 2008 г.; 84(3): 192 - 202. doi: 10.2223/JPED.1773

294. Криулин И.А., Алексеева Е.И., Шилькрот И.Ю., Дворяковская Т.М. Лечение вторичного гемофагоцитарного синдрома у пациентов с системным ювенильным идиопатическим артритом. Результаты когортного ретроспективного исследования. Вопросы практической педиатрии. 2022; 17(5): 7 - 19. DOI: 10.20953/1817-7646-2022-5-7-19.

295. Mouy R, Stephan JL, Pillet P, Haddad E, Hubert P, Prieur AM. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: Report of five cases. J Pediatr. ноябрь 1996 г.; 129(5): 750 - 4. doi: 10.1016/S0022-3476(96) 70160-9

296. Georgiadou S, Gatselis NK, Stefos A, Zachou K, Makaritsis K, Rigopoulou EI, и др. Efficient management of secondary haemophagocytic lymphohistiocytosis with intravenous steroids and Рисунок 152 infusions. World J Clin Cases. 6 ноябрь 2019 г.; 7(21): 3394 - 406. doi: 10.12998/wjcc.v7.i21.3394

297. Sen E. S., Clarke S. L. N., Ramanan A. V. Macrophage activation syndrome//The Indian Journal of Pediatrics. - 2016. - Т. 83. - N. 3. - С. 248 - 253.

298. Papa R, Natoli V, Caorsi R, Minoia F, Gattorno M, Ravelli A. Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases. Pediatr Rheumatol. декабрь 2020 г.; 18(1): 56. doi: 10.1186/s12969-020-00450-9

299. Bhat CS, Shetty R, Ramesh D, Banu A, Ramanan AV. Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C). Indian Pediatr. октябрь 2021 г.; 58(10): 994 - 6. doi: 10.1007/s13312-021-2340-1

300. Kostik MM, Isupova EA, Belozerov K, Likhacheva TS, Suspitsin EN, Raupov R, и др. Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis. Front Pediatr. 28 июль 2022 г.; 10: 894846. doi: 10.3389/fped.2022.894846

301. Phadke O, Rouster-Stevens K, Giannopoulos H, Chandrakasan S, Prahalad S. Intravenous administration of anakinra in children with macrophage activation syndrome. Pediatr Rheumatol. декабрь 2021 г.; 19(1): 98. doi: 10.1186/s12969-021-00585-3

302. Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML, и др. Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis. Arthritis Rheumatol. февраль 2020 г.; 72(2): 326 - 34. doi: 10.1002/art.41103

303. Pal P, Bathia J, Giri PP, Roy M, Nandi A. Macrophage activation syndrome in pediatrics: 10 years data from an Indian center. Int J Rheum Dis. октябрь 2020 г.; 23(10): 1412 - 6. doi: 10.1111/1756-185X.13915

304. Kostik MM, Raupov RK, Suspitsin EN, Isupova EA, Gaidar EV, Gabrusskaya TV, и др. The Safety and Efficacy of Tofacitinib in 24 Cases of Pediatric Rheumatic Diseases: Single Centre Experience. Front Pediatr. 8 февраль 2022 г.; 10: 820586. doi: 10.3389/fped.2022.820586

305. Wei A, Ma H, Li Z, Zhang L, Zhang Q, Wang D, и др. Short-term effectiveness of ruxolitinib in the treatment of recurrent or refractory hemophagocytic lymphohistiocytosis in children. Int J Hematol. октябрь 2020 г.; 112(4): 568 - 76. doi: 10.1007/s12185-020-02936-4

306. Clemente D, Cuadros EN, Lovillo MC, Рисунок 153 JC, Рисунок 154 SG, Silveira LF, и др. Position statement on infection screening, prophylaxis, and vaccination of pediatric patients with rheumatic diseases and immunosuppressive therapies, part 3: precautions in situations of surgery, fever, and opportunistic infections. Eur J Pediatr. 4 декабрь 2023 г.; 183(2): 915 - 27. doi: 10.1007/s00431-023-05295-4

307. Rao S, Abzug MJ, Carosone-Link P, Peterson T, Child J, Siparksy G, и др. Intravenous Acyclovir and Renal Dysfunction in Children: A Matched Case Control Study. J Pediatr. июнь 2015 г.; 166(6): 1462-1468.e4. doi: 10.1016/j.jpeds.2015.01.023

308. Kimberlin DW. Acyclovir Dosing in the Neonatal Period and Beyond. J Pediatr Infect Dis Soc. 1 июнь 2013 г.; 2(2): 179 - 82. doi: 10.1093/jpids/pis138

309. Widasmara D, Firdausiya F. Disseminated Herpes Zoster on a Child with Systemic Lupus Erythematosus and Lupus Nephritis. Infect Drug Resist. июль 2021 г.; Volume 14: 2777 - 85. doi: 10.2147/IDR.S314220

310. Balfour HH, McMonigal KA, Bean B. Acyclovir therapy of varicella-zoster virus infections in immunocompromised patients. J Antimicrob Chemother. 1 январь 1983 г.; 12(suppl B): 169 - 79. doi: 10.1093/jac/12.suppl_B.169

311. Shim GH. Treatment of congenital cytomegalovirus infection. Clin Exp Pediatr. 15 сентябрь 2023 г.; 66(9): 384 - 94. doi: 10.3345/cep.2022.01032

312. Lin X, Wan Y, Liu Y. Efficacy of ganciclovir in the treatment of cytomegalovirus (CMV) infection in infants and its effect on inflammatory reaction and immune function. Am J Transl Res. 2023; 15: 6514 - 23.

313. Antiviral Drugs in Children and Adolescents. Pediatr Infect Dis. 16 июль 2020 г.; 1(3): 123 - 8. doi: 10.5005/jp-journals-10081-1221

314. Zhang S, Zhu Y, Jin Y, Sun H, Wang W, Zhan L. Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein-Barr Virus-Associated Infectious Mononucleosis. Tan S, редактор. Evid Based Complement Alternat Med. 20 октябрь 2021 г.; 2021: 1 - 6. doi: 10.1155/2021/8996934

315. Fitzmaurice MG, Srinivas P, Eckardt J, Koval C, Koval C, Lum J. 582. Safety and Efficacy of High-Dose Ganciclovir versus Standard Dosing for Cytomegalovirus Viremia in Solid Organ Transplant (SOT) Recipients. Open Forum Infect Dis. 31 декабрь 2020 г.; 7 (Supplement_1): S356-S356. doi: 10.1093/ofid/ofaa439.776

316. Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, и др. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. август 2013 г.; 162(3): 376 - 82. doi: 10.1111/bjh.12386

317. Siberry GK, Abzug MJ, Nachman S, Brady MT, Dominguez KL, Handelsman E, и др. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Exposed and HIV-Infected Children: Recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. Pediatr Infect Dis J. ноябрь 2013 г.; 32 (Supplement 2): i. doi: 10.1097/01.inf.0000437856.09540.11

318. Green H, Paul M, Vidal L, Leibovici L. Prophylaxis of Pneumocystis Pneumonia in Immunocompromised Non-HIV-Infected Patients: Systematic Review and Meta-analysis of Randomized Controlled Trials. Mayo Clin Proc. сентябрь 2007 г.; 82(9): 1052 - 9. doi: 10.4065/82.9.1052

319. Abe Y, Fujibayashi K, Nishizaki Y, Yanagisawa N, Nojiri S, Nakano S, и др. Conventional-dose Versus Half-dose Sulfamethoxazole-trimethoprim for the Prophylaxis of Pneumocystis Pneumonia in Patients with Systemic Rheumatic Disease: A Non-blind, Randomized Controlled Trial [Интернет]. Okayama University Medical School; 2019 [цитируется по 2 октябрь 2022 г.]. Доступно на: https://doi.org/10.18926/AMO/56464 doi: 10.18926/AMO/56464

320. Ghembaza A, Vautier M, Cacoub P, Pourcher V, Saadoun D. Risk Factors and Prevention of Pneumocystis jirovecii Pneumonia in Patients With Autoimmune and Inflammatory Diseases. Chest. декабрь 2020 г.; 158(6): 2323 - 32. doi: 10.1016/j.chest.2020.05.558

321. Jiang X, Mei X, Feng D, Wang X. Prophylaxis and Treatment of Pneumocystis jiroveci Pneumonia in Lymphoma Patients Subjected to Rituximab-Contained Therapy: A Systemic Review and Meta-Analysis. Tanowitz HB, редактор. PLOS ONE. 24 апрель 2015 г.; 10(4): e0122171. doi: 10.1371/journal.pone.0122171

322. Kitazawa T, Seo K, Yoshino Y, Asako K, Kikuchi H, Kono H, и др. Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases. J Infect Chemother. май 2019 г.; 25(5): 351 - 4. doi: 10.1016/j.jiac.2019.01.005

323. Park JW, Curtis JR, Kim MJ, Lee H, Song YW, Lee EB. Pneumocystis pneumonia in patients with rheumatic diseases receiving prolonged, non-high-dose steroids-clinical implication of primary prophylaxis using trimethoprim-sulfamethoxazole. Arthritis Res Ther. декабрь 2019 г.; 21(1): 207. doi: 10.1186/s13075-019-1996-6

324. What's New Adult and Adolescent Opportunistic Infection. AIDSinfo. https://aidsinfo.nih.gov/guidelines/html/4/adult-and-adolescent-opportunistic-infection/392/whats-new (accessed 14 Apr 2020).

325. Thomas KN, Aggarwal A. Childhood rheumatic diseases: bites not only the joint, but also the heart. Clin Rheumatol. октябрь 2023 г.; 42(10): 2703 - 15. doi: 10.1007/s10067-023-06621-9

326. Shimizu M, Nakagishi Y, Inoue N, Mizuta M, Ko G, Saikawa Y, и др. Interleukin-18 for predicting the development of macrophage activation syndrome in systemic juvenile idiopathic arthritis. Clin Immunol. октябрь 2015 г.; 160(2): 277 - 81. doi: 10.1016/j.clim.2015.06.005

327. Andrews A, Hickling P. Thrombosis associated with antiphospholipid antibody in juvenile chronic arthritis. Lupus. июль 1997 г.; 6(6): 556 - 7. doi: 10.1177/096120339700600616

328. Valade S, Mariotte E, Azoulay E. Coagulation Disorders in Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome. Crit Care Clin. апрель 2020 г.; 36(2): 415 - 26. doi: 10.1016/j.ccc.2019.12.004

329. Carcillo JA, Shakoory B, Castillo L. Secondary Hemophagocytic Lymphohistiocytosis, Macrophage Activation Syndrome, and Hyperferritinemic Sepsis-Induced Multiple-Organ Dysfunction Syndrome in the Pediatric ICU. In: Mastropietro CW, Valentine KM, eds. Pediatric Critical Care. Cham: Springer International Publishing 2019: 245 - 55.

330. Yilmaz D., Ritchey A. K. Severe neutropenia in children: a single institutional experience//Journal of Pediatric Hematology/Oncology. - 2007. - Т. 29. - N. 8. - С. 513 - 518.

331. Алексеева Е., Валиева С., Бзарова Т., Семикина Е., Исаева К., Лисицин А., Денисова Р., Чистякова Е., Слепцова Т., Митенко Е. Эффективность и безопасность отечественного рекомбинантного человеческого гранулоцитарного колониестимулирующего фактора при нейтропениях, развивающихся на фоне анти-в клеточной и иммуносупрессивной терапии у больных ювенильным ревматоидным артритом. Вопросы современной педиатрии. 2010; 9(4): 94 - 100.

332. Ahmadinejad Z, Mansori S, Ziaee V, et al. Periodic Fever: a review on clinical, management and guideline for Iranian patients - part I. Iran J Pediatr 2014; 24: 1 - 13.

333. Chien YL, Huang FL, Huang CM, Chen PY. Clinical approach to fever of unknown origin in children. J Microbiol Immunol Infect. декабрь 2017 г.; 50(6): 893 - 8. doi: 10.1016/j.jmii.2015.08.007

334. Jog NR, Young KA, Munroe ME, Harmon MT, Guthridge JM, Kelly JA, и др. Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals. Ann Rheum Dis. сентябрь 2019 г.; 78(9): 1235 - 41. doi: 10.1136/annrheumdis-2019-215361

335. Segel, G. B., & Halterman, J. S. (2008). Neutropenia in pediatric practice. Pediatrics in review, 29(1), 12.

336. Demirkol D, Yildizdas D, Bayrakci B, Karapinar B, Kendirli T, Koroglu TF, и др. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment? Crit Care. 19 март 2012 г.; 16(2): R52. doi: 10.1186/cc11256

337. Henter J, Horne A, Рисунок 155 M, Egeler RM, Filipovich AH, Imashuku S, и др. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. февраль 2007 г.; 48(2): 124 - 31. doi: 10.1002/pbc.21039

338. Stucki G, Kroeling P. Physical therapy and rehabilitation in the management of rheumatic disorders. Best Pract Res Clin Rheumatol. декабрь 2000 г.; 14(4): 751 - 71. doi: 10.1053/berh.2000.0111

339. Luttosch F, Baerwald C. Rehabilitation in der Rheumatologie. Internist. октябрь 2010 г.; 51(10): 1239 - 45. doi: 10.1007/s00108-010-2626-1

340. Frye WS, Milojevic D. The Role of Psychology in Pediatric Rheumatic Diseases. Pediatr Clin North Am. октябрь 2022 г.; 69(5): 965 - 74. doi: 10.1016/j.pcl.2022.05.009

341. Heijstek MW, Ott de Bruin LM, Bijl M, Borrow R, van der Klis F, Рисунок 156 I, и др. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann Rheum Dis. октябрь 2011 г.; 70(10): 1704 - 12. doi: 10.1136/ard.2011.150193

342. Кокина М.Ю., Фомина Д.С., Лебедкина М.С., Мутовина З.Ю., Жолобова Е.С., Курбанова С.Х., Наргизян А.К., Фетисова А.Н., Анджель А.Е., Дворяковская Т.М., Шилькрот И.Ю., Алексеева Е.И. Эффективность и безопасность применения двухкомпонентного препарата моноклональных антител к SARS-CoV-2 (тиксагевимаб + цилгавимаб) для доконтактной профилактики новой коронавирусной инфекции у иммунокомпрометированных пациентов детского возраста с ревматическими заболеваниями. Предварительные результаты первого в Российской Федерации проспективного наблюдательного когортного исследования. Вопросы практической педиатрии. 2023; 18(1): 16 - 26.

343. Jansen MHA, Rondaan C, Legger GE, Minden K, Uziel Y, Toplak N, и др. EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021. Ann Rheum Dis. январь 2023 г.; 82(1): 35 - 47. doi: 10.1136/annrheumdis-2022-222574

344. Navallas M, Inarejos Clemente EJ, Iglesias E, Rebollo-Polo M, Рисунок 157 JC, Navarro OM. Autoinflammatory diseases in childhood, part 2: polygenic syndromes. Pediatr Radiol. март 2020 г.; 50(3): 431 - 44. doi: 10.1007/s00247-019-04544-9

345. Yilmaz D., Ritchey A. K. Severe neutropenia in children: a single institutional experience//Journal of Pediatric Hematology/Oncology. - 2007. - Т. 29. - N. 8. - С. 513 - 518.

346. Novelli, V., & Holzel, H. (1999). Safety and tolerability of fluconazole in children. Antimicrobial agents and chemotherapy, 43(8), 1955 - 1960.

347. Aghdashi MA, Khadir M, Dinparasti-Saleh R. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept. Curr Rheumatol Rev. 5 март 2020 г.; 16(1): 61 - 6. doi: 10.2174/1573397115666190506152729

348. Scientific Centre of Children's Health, Moscow, Russian Federation, Alexeeva EI, Denisova RV, Scientific Centre of Children's Health, Moscow, Russian Federation, Chomakhidze AM, Scientific Centre of Children's Health, Moscow, Russian Federation. Intravenous Immunoglobulin in Pediatric Rheumatology Practice. Curr Pediatr Vopr Sovrem Pediatr. 2015 г.; 14(2): 219 - 23. doi: 10.15690/vsp.v14i2.1290

349. Garcia-Lloret M, McGhee S, Chatila TA. Immunoglobulin Replacement Therapy in Children. Immunol Allergy Clin North Am. ноябрь 2008 г.; 28(4): 833 - 49. doi: 10.1016/j.iac.2008.07.001

350. Rodriguez MM, Wagner-Weiner L. Intravenous Immunoglobulin in Pediatric Rheumatology: When to Use It and What Is the Evidence. Pediatr Ann. январь 2017 г.; 46(1). doi: 10.3928/19382359-20161214-01

351. Prasad AN, Chaudhary S. Intravenous immunoglobulin in pediatrics: A review. Med J Armed Forces India. июль 2014 г.; 70(3): 277 - 80. doi: 10.1016/j.mjafi.2013.05.011

352. Mulhearn B, Bruce IN. Indications for IVIG in rheumatic diseases. Rheumatology. 1 март 2015 г.; 54(3): 383 - 91. doi: 10.1093/rheumatology/keu429

353. Chien YL, Huang FL, Huang CM, Chen PY. Clinical approach to fever of unknown origin in children. J Microbiol Immunol Infect. декабрь 2017 г.; 50(6): 893 - 8. doi: 10.1016/j.jmii.2015.08.007

354. El-Nawawy A, El-Kinany H, Hamdy El-Sayed M, Boshra N. Intravenous Polyclonal Immunoglobulin Administration to Sepsis Syndrome Patients: A Prospective Study in a Pediatric Intensive Care Unit. J Trop Pediatr. 1 октябрь 2005 г.; 51(5): 271 - 8. doi: 10.1093/tropej/fmi011

355. Рисунок 158 N, Makay B, Рисунок 159 B. Long-term effectiveness and safety of canakinumab in pediatric familial Mediterranean fever patients. Mod Rheumatol. 2 январь 2020 г.; 30(1): 166 - 71. doi: 10.1080/14397595.2018.1559488

356. Rao S, Abzug MJ, Carosone-Link P, Peterson T, Child J, Siparksy G, и др. Intravenous Acyclovir and Renal Dysfunction in Children: A Matched Case Control Study. J Pediatr. июнь 2015 г.; 166(6): 1462 - 1468. e4. doi: 10.1016/j.jpeds.2015.01.023

357. Whitley RJ. Herpes simplex virus in children. Curr Treat Options Neurol. май 2002 г.; 4(3): 231 - 7. doi: 10.1007/s11940-002-0040-2

358. Antiviral Drugs in Children and Adolescents. Pediatr Infect Dis. 16 июль 2020 г.; 1(3): 123 - 8. doi: 10.5005/jp-journals-10081-1221

359. 359. Zhang S, Zhu Y, Jin Y, Sun H, Wang W, Zhan L. Difference between Acyclovir and Ganciclovir in the Treatment of Children with Epstein-Barr Virus-Associated Infectious Mononucleosis. Tan S, редактор. Evid Based Complement Alternat Med. 20 октябрь 2021 г.; 2021: 1 - 6. doi: 10.1155/2021/8996934

360. Рисунок 160 R, Рисунок 161 HE, Рисунок 162 M, Рисунок 163, Tanatar A, Рисунок 164 F, и др. Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center. Rheumatol Int. май 2020 г.; 40(5): 771 - 6. doi: 10.1007/s00296-019-04498-z

361. Рисунок 165 J, Roggentin P. Enterale Yersiniosen. Klinische Bedeutung, Epidemiologie, Diagnostik und Рисунок 166 [Intestinal yersiniosis. Clinical importance, epidemiology, diagnosis, and prevention]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2004 Jul; 47(7): 685 - 91

362. Sandau KE, Funk M, Auerbach A, Barsness GW, Blum K, Cvach M, и др. Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association. Circulation. 7 ноябрь 2017 г.; 136(19). doi: 10.1161/CIR.0000000000000527

363. Sharma AP, Norozi K, Filler G, Altamirano-Diaz L. Diagnosis of Pediatric Hypertension: European Society of Hypertension-recommended 24-hr vs. 24-hr-day-night Ambulatory Blood Pressure thresholds. 23.

364. Turner D, Levine A, Escher JC, Griffiths AM, Russell RK, Dignass A, и др. Management of Pediatric Ulcerative Colitis: Joint ECCO and ESPGHAN Evidence-based Consensus Guidelines. J Pediatr Gastroenterol Nutr. сентябрь 2012 г.; 55(3): 340 - 61. doi: 10.1097/MPG.0b013e3182662233

365. Belmer SV, Kornienko EA, Volynets GV, Gurova MM, Zvyagin AA, Kamalova AA, и др. Diagnostics and treatment of Helicobacter pylori infection in children. Exp Clin Gastroenterol. 11 декабрь 2021 г.; (9): 119 - 27. doi: 10.31146/1682-8658-ecg-193-9-119-127

366. Kotilea K, Cadranel S, Salame A, Nguyen J, Mahler T, Miendje Deyi VY, и др. Efficacy and safety of bismuth-based quadruple therapy for Helicobacter pylori eradication in children. Helicobacter. август 2021 г.; 26(4): e12825. doi: 10.1111/hel.12825

367. Pneumonia in Immunocompromised Patients: Overview, Causes of Pneumonia, HIV/AIDS. Published Online First: 23 March 2020. https://emedicine.medscape.com/article/807846-overview#a11. (accessed 14 Apr 2020).

368. Efthimiou P, SpringerLink (Online service). Auto-Inflammatory Syndromes Pathophysiology, Diagnosis, and Management. 2019.

369. Weyant RB, Kabbani D, Doucette K, Lau C, Cervera C. Pneumocystis jirovecii: a review with a focus on prevention and treatment. Expert Opin Pharmacother. 13 август 2021 г.; 22(12): 1579-92. doi: 10.1080/14656566.2021.1915989

370. Douglas AP, Smibert OliviaC, Bajel A, Halliday CL, Lavee O, McMullan B, и др. Consensus guidelines for the diagnosis and management of invasive aspergillosis, 2021. Intern Med J. ноябрь 2021 г.; 51(S7): 143 - 76. doi: 10.1111/imj.15591

371. Денисова Р.В., Алексеева Екатерина Иосифовна, Пинелис В.Г., Баканов М.И., Валиева С.И., Бзарова Т.М., Исаева К.Б., Морев С.Ю., Кузнецова Г.В., Арсеньева Е.Н., Малахов О.А. Эффективность и безопасность ибандроновой кислоты для внутривенного введения при тяжелом системном остеопорозе у больных ювенильным артритом//ВСП. 2011. N 6.

372. Kutilek S, Plasilova I, Langer J. Ibandronate in the treatment of pediatric osteoporosis. Bone Abstr. 9 июнь 2015 г. doi: 10.1530/boneabs.4.P80

373. Allen-Rhoades W, Whittle SB, Rainusso N. Pediatric Solid Tumors in Children and Adolescents: An Overview. Pediatr Rev. 1 сентябрь 2018 г.; 39(9): 444 - 53. doi: 10.1542/pir.2017-0268

374. Захарова И.Н., Османов И.М., Творогова Т.М., Горяйнова А.Н., Дмитриева Ю.А., Воробьева А.С., Короид Н.В. Длительная лихорадка у ребенка: в чем причина, как обследовать, лечить или не лечить? Медицинский совет. 2020; (10): 151 - 162. doi: 10.21518/2079-701X-2020-10-151-162.

375. Alias A, Rodriguez EJ, Bateman HE, et al. Rheumatology and oncology: an updated review of rheumatic manifestations of malignancy and anti-neoplastictherapy. Bull NYU Hosp Jt Dis. 2012; 70: 109 - 14.

376. Loctin A, Bailly F, Laroche D, Tavernier C, Maillefert JF, Ornetti P. Clinical interest of bone marrow aspiration in rheumatology: a practice-based observational study of 257 bone marrow aspirations. Clin Rheumatol. январь 2013 г.; 32(1): 115 - 21. doi: 10.1007/s10067-012-2097-y

377. Trapani S, Grisolia F, Simonini G, Battista Calabri G, Falcini F. Incidence of occult cancer in children presenting with musculoskeletal symptoms: A 10-year survey in a pediatric rheumatology unit. Semin Arthritis Rheum. июнь 2000 г.; 29(6): 348 - 59. doi: 10.1053/sarh.2000.5752

378. Рисунок 167 JB. New imaging techniques in reumathology: MRI, scintigraphy and PET. Pol J Radiol. 2013 г.; 78(3): 48 - 56. doi: 10.12659/PJR.889138

379. Demirkaya E, Ozen S, Рисунок 168 T, Kuis W, Saurenmann RK. Current educational status of paediatric rheumatology in Europe: the results of PReS survey. Clin Exp Rheumatol. август 2009 г.; 27(4): 685 - 90. PubMed PMID: 19772807.

380. de Camargo MC, Barros BCA, Fulone I, Silva MT, Silveira MS do N, Camargo IA de, и др. Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting. Front Pharmacol. 11 сентябрь 2019 г.; 10: 965. doi: 10.3389/fphar.2019.00965

381. Puxeddu I, Giori L, Rocchi V, Bazzichi L, Bombardieri S, Tavoni A, и др. Hypersensitivity reactions during treatment with infliximab, etanercept, and adalimumab. Ann Allergy Asthma Immunol. февраль 2012 г.; 108(2): 123 - 4. doi: 10.1016/j.anai.2011.11.004

382. Dale DC, Crawford J, Klippel Z, Reiner M, Osslund T, Fan E, и др. A systematic literature review of the efficacy, effectiveness, and safety of filgrastim. Support Care Cancer. январь 2018 г.; 26(1): 7 - 20. doi: 10.1007/s00520-017-3854-x

383. Garcia-Lloret M, McGhee S, Chatila TA. Immunoglobulin Replacement Therapy in Children. Immunol Allergy Clin North Am. ноябрь 2008 г.; 28(4): 833 - 49. doi: 10.1016/j.iac.2008.07.001